Detecting susceptibility to malignant hyperthermia.
- 28 March 1992
- Vol. 304 (6830) , 791-792
- https://doi.org/10.1136/bmj.304.6830.791
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Another death from Ecstacy.1992
- A substitution of cysteine for arginine 614 in the ryanodine receptor is potentially causative of human malignant hyperthermiaGenomics, 1991
- Evidence for genetic heterogeneity in malignant hyperthermia susceptibilityGenomics, 1991
- Diagnosis of susceptibility to malignant hyperthermia with flanking DNA markers.BMJ, 1991
- Identification of a Mutation in Porcine Ryanodine Receptor Associated with Malignant HyperthermiaScience, 1991
- Localization of the malignant hyperthermia susceptibility locus to human chromosome 19ql2–13.2Nature, 1990
- Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermiaNature, 1990
- The association between the neuroleptic malignant syndrome and malignant hyperthermiaActa Anaesthesiologica Scandinavica, 1989
- A PROTOCOL FOR THE INVESTIGATION OF MALIGNANT HYPERPYREXIA (MH) SUSCEPTIBILITYBritish Journal of Anaesthesia, 1984
- METABOLIC ERROR OF MUSCLE METABOLISM AFTER RECOVERY FROM MALIGNANT HYPERTHERMIAThe Lancet, 1970